The latest Reclast study emphasizes the importance of treating patients for osteoporosis after a hip fracture

The latest Reclast study emphasizes the importance of treating patients for osteoporosis after a hip fracture.

Elderly patients who break a hip have a high risk of disability, future fractures, and even death.

Now there's evidence that Reclast (zoledronic acid) reduces the risk of a second fracture and improves survival in these patients.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote